BCD-131

BIOLOGICAL2 trials

Sponsors

Biocad

Conditions

AnemiaReticulocyte Count

Phase 1

Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

CompletedNCT02731469

BiocadReticulocyte Count

Start: 2016-06-15End: 2017-03-31Updated: 2019-07-01

Phase 2

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

CompletedNCT03519243

Start: 2017-10-24End: 2018-12-10Updated: 2021-03-04